Gary Kohanbash

6.1k total citations · 1 hit paper
76 papers, 3.9k citations indexed

About

Gary Kohanbash is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Gary Kohanbash has authored 76 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 28 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Gary Kohanbash's work include Glioma Diagnosis and Treatment (23 papers), Immunotherapy and Immune Responses (20 papers) and Immune cells in cancer (17 papers). Gary Kohanbash is often cited by papers focused on Glioma Diagnosis and Treatment (23 papers), Immunotherapy and Immune Responses (20 papers) and Immune cells in cancer (17 papers). Gary Kohanbash collaborates with scholars based in United States, China and Israel. Gary Kohanbash's co-authors include Hideho Okada, Mitsugu Fujita, Ryo Ueda, Ronald L. Hamilton, John R. Ohlfest, Manish K. Aghi, Heather A. McDonald, Edward R. Kastenhuber, Wendy Fellows-Mayle and Xinmei Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Gary Kohanbash

69 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment

2017 434 citations Sören Müller, Gary Kohanbash et al. profile →

Peers

Countries citing papers authored by Gary Kohanbash

Since Specialization

Citations

This map shows the geographic impact of Gary Kohanbash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Kohanbash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Kohanbash more than expected).

Fields of papers citing papers by Gary Kohanbash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Kohanbash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Kohanbash. The network helps show where Gary Kohanbash may publish in the future.

Co-authorship network of co-authors of Gary Kohanbash

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Kohanbash. A scholar is included among the top collaborators of Gary Kohanbash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Kohanbash. Gary Kohanbash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy 2025 ·Genes and Immunity ·(unknown), (unknown), (unknown), Jorge Reinheimer, (unknown), (unknown), Ahmed Habib, Baoli Hu, Sameer Agnihotri, Dhivyaa Rajasundaram, Pascal O. Zinn, Thomas G. Forsthuber, Ian F. Pollack, Xuejun Li, Itay Raphael, Gary Kohanbash	0
2	Barriers to T Cell Functionality in the Glioblastoma Microenvironment 2024 ·Cancers ·(unknown), (unknown), (unknown), Sakibul Huq, Xiaoran Zhang, Gary Kohanbash, Constantinos G. Hadjipanayis	3
3	Survival following complete resection of neuroblastoma in novel orthotopic rat xenograft model 2023 ·Scientific Reports ·(unknown), Lauren Rosenblum, Miguel Reyes‐Múgica, Wilson B. Edwards, Marcus M. Malek, Gary Kohanbash	1
4	Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models 2023 ·STAR Protocols ·Apeng Chen, Yapeng Chao, Han Zou, Lauren McCarl, Gary Kohanbash, Baoli Hu	4
5	Handheld PET Probe for Pediatric Cancer Surgery 2022 ·Cancers ·(unknown), (unknown), Ryan J. Gilbert, (unknown), Wilson B. Edwards, Gary Kohanbash, Marcus M. Malek	7
6	Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines 2022 ·Cancers ·Ashok Panigrahy, Regina I. Jakacki, Ian F. Pollack, Rafael Ceschin, Hideho Okada, Marvin D. Nelson, Gary Kohanbash, Girish Dhall, Stefan Blüml	4
7	Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice 2021 ·Neuro-Oncology ·Pavlina Chuntova, Yafei Hou, (unknown), Akane Yamamichi, Tiffany Chen, Yitzhar Goretsky, Ryusuke Hatae, Takahide Nejo, Gary Kohanbash, (unknown), (unknown), Kira Downey, (unknown), (unknown), Hong-Erh Liang, Bjoern Schwer, Hideho Okada	11
8	Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment 2021 ·Molecular Therapy — Oncolytics ·Joseph W. Jackson, Bonnie L. Hall, (unknown), (unknown), Lisa Bailey, E. Antonio Chiocca, William F. Goins, Gary Kohanbash, Justus B. Cohen, Joseph C. Glorioso	7
9	Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces Astrogliosis 2020 ·Molecular Cancer Therapeutics ·Lanxin Luo, Xiudong Guan, Gulnaz Begum, Dawei Ding, (unknown), Md Nabiul Hasan, Victoria M. Fiesler, (unknown), Gary Kohanbash, Baoli Hu, Nduka Amankulor, Wang Jia, María G. Castro, Baoshan Sun, Dandan Sun	19
10	The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation 2019 ·Cancer Discovery ·Lin Wang, Husam Babikir, Sören Müller, Garima Yagnik, Karin Shamardani, Francisca Catalan, Gary Kohanbash, Beatriz Alvarado, Elizabeth Di Lullo, Arnold R. Kriegstein, Sumedh S. Shah, Harsh Wadhwa, Susan M. Chang, Joanna J. Phillips, Manish K. Aghi, Aarón Díaz	194
11	Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomas 2018 ·JCI Insight ·Sören Müller, Sameer Agnihotri, (unknown), (unknown), (unknown), Srilakshmi Chaparala, (unknown), Ansuman Chattopadhyay, Adrian V. Lee, Lisa H. Butterfield, Aarón Díaz, Hideho Okada, Ian F. Pollack, Gary Kohanbash	24
12	Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice 2016 ·PubMed ·(unknown), Kah-Whye Peng, (unknown), (unknown), Hong Ma, Gary Kohanbash, Joanna J. Phillips, Corey Raffel	7
13	Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC 2014 ·Clinical Cancer Research ·Hideho Okada, Lisa H. Butterfield, Ronald L. Hamilton, Aki Hoji, Masashi Sakaki, Brian Ahn, Gary Kohanbash, Jan Drappatz, Johnathan A. Engh, Nduka Amankulor, Mark O. Lively, Michael D. Chan, Andres Μ. Salazar, Edward G. Shaw, Douglas M. Potter, Frank S. Lieberman	83
14	GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α 2013 ·Cancer Research ·Gary Kohanbash, (unknown), Masashi Sakaki, Ryo Ueda, Arlan Mintz, Nduka Amankulor, Mitsugu Fujita, John R. Ohlfest, Hideho Okada	134
15	COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells 2011 ·Cancer Research ·Mitsugu Fujita, Gary Kohanbash, Wendy Fellows-Mayle, Ronald L. Hamilton, Yoshihiro Komohara, Stacy A. Decker, John R. Ohlfest, Hideho Okada	315
16	Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans 2010 ·Clinical Cancer Research ·Mitsugu Fujita, Michael E. Scheurer, Stacy A. Decker, Heather A. McDonald, Gary Kohanbash, Edward R. Kastenhuber, Hisashi Kato, Melissa L. Bondy, John R. Ohlfest, Hideho Okada	76
17	Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners 2010 ·Cancer Immunology Immunotherapy ·Xinmei Zhu, (unknown), Mitsugu Fujita, Ryo Ueda, Gary Kohanbash, Edward R. Kastenhuber, Heather A. McDonald, Yan Liu, Paweł Kaliński, Todd A. Reinhart, Andres Μ. Salazar, Hideho Okada	71
18	Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines 2009 ·Clinical Cancer Research ·Ryo Ueda, Mitsugu Fujita, Xinmei Zhu, Kotaro Sasaki, Edward R. Kastenhuber, Gary Kohanbash, Heather A. McDonald, Jay Harper, Scott Lonning, Hideho Okada	94
19	Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10 2009 ·Cancer Research ·Mitsugu Fujita, Xinmei Zhu, Ryo Ueda, Kotaro Sasaki, Gary Kohanbash, Edward R. Kastenhuber, Heather A. McDonald, Gregory A. Gibson, Simon C. Watkins, Ravikumar Muthuswamy, Paweł Kaliński, Hideho Okada	84
20	Dicer-regulated micro RNAs 222 and 339 promote immune-escape of cancer cells through downregulation of ICAM-1 2008 ·Cancer Research ·Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, Mitsugu Fujita, Xinmei Zhu, Michael T. Lotze, Robert W. Sobol, Hideho Okada	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact